The ClinGen Evidence Repository is an FDA-recognized human genetic variant database containing expert-curated assertions regarding variants' pathogenicity and supporting evidence summaries. [Disclaimer]


Variant: NM_000152.5(GAA):c.1193del (p.Leu398fs)

CA16041891

371457 (ClinVar)

Gene: GAA
Condition: glycogen storage disease II
Inheritance Mode: Autosomal recessive inheritance
UUID: 0e9ea75d-d13a-4057-8f8e-ffac66ee7c57

HGVS expressions

NM_000152.5:c.1193del
NM_000152.5(GAA):c.1193del (p.Leu398fs)
NC_000017.11:g.80108606del
CM000679.2:g.80108606del
NC_000017.10:g.78082405del
CM000679.1:g.78082405del
NC_000017.9:g.75697000del
NG_009822.1:g.12051del
ENST00000302262.8:c.1193del
ENST00000302262.7:c.1193del
ENST00000390015.7:c.1193del
NM_000152.3:c.1193del
NM_001079803.1:c.1193del
NM_001079804.1:c.1193del
NM_000152.4:c.1193del
NM_001079803.2:c.1193del
NM_001079804.2:c.1193del
NM_001079803.3:c.1193del
NM_001079804.3:c.1193del

Likely Pathogenic

The Expert Panel has overridden the computationally generated classification - "Uncertain Significance - Insufficient Evidence"
Met criteria codes 2
PVS1 PM2_Supporting
Not Met criteria codes 1
PP4

Evidence Links 0

Expert Panel

Criteria Specification Information

Criteria Specification: ClinGen Lysosomal Storage Disorders Variant Curation Expert Panel Specifications to the ACMG/AMP Variant Interpretation Guidelines Version 2

Criteria Specification Approval History
Criteria Specifications for this VCEP
Evidence submitted by expert panel
Lysosomal Diseases VCEP
The NM_000152.5:c.1193del (p.Leu398ArgfsTer42) variant in GAA is a frameshift variant predicted to cause a premature stop codon, leading to nonsense mediated decay in a gene in which loss-of-function is an established disease mechanism (PVS1). This variant is not in gnomAD v2.1.1. (PM2_Supporting). This variant has been reported in one patient with POmpe disease; however residual GAA activity was not provided and the second variant is not reported (PMID 30155607). There is a ClinVar entry for this variant (Variation ID: 371457). The classification of this variant has been upgraded from Variant of Uncertain Significance to Likely Pathogenic based on the recommendations of the ClinGen Sequence Variant Interpretation Working Group, that a variant meeting PVS1 and PM2_Supporting is classified as Likely Pathogenic (https://clinicalgenome.org/site/assets/files/5182/pm2_-_svi_recommendation_-_approved_sept2020.pdf ). In summary, this variant meets the criteria to be classified as likely pathogenic for Pompe disease. GAA-specific ACMG/AMP criteria met, based on the specifications of the ClinGen Lysosomal Diseases VCEP (Specifications Version 2.0): PVS1, PM2_Supporting. (Classification approved by the ClinGen Lysosomal Diseases VCEP, March 10, 2023).
Met criteria codes
PVS1
The NM_000152.5:c.1193del (p.Leu398ArgfsTer42) variant in GAA is a frameshift variant predicted to cause a premature stop codon, leading to nonsense mediated decay in a gene in which loss-of-function is an established disease mechanism (PVS1).
PM2_Supporting
This variant is not in gnomAD v2.1.1. (PM2_Supporting).
Not Met criteria codes
PP4
This variant has been reported in one patient (PMID 30155607); however the residual GAA activity was not provided and therefore the ClinGen LD VCEP’s specifications for PP4 are not met at the current time.
Approved on: 2023-03-10
Published on: 2023-03-10
The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. If you have questions about the information contained on this website, please see a health care professional.
¤ Powered by BCM's Genboree.